MedPath

OPTREX EYE DROPS

OPTREX EYE DROPS

Discontinued
DIN Number

02185482

Drug Class

Human

Market Date

Dec 31, 1996

Company
HC

knoll pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02185482
AIG Number0512389001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01AX07 SODIUM BORATE
Product Specifications
Dosage FormDrops
Route of AdministrationOphthalmic
AHFS Classification52:04.92
Health Canada Classification

ACTIVE INGREDIENTS (5)

ALLANTOINActive
Strength: 0.08 %
Monograph: ALLANTOIN
BORIC ACIDActive
Strength: 1.08 %
Monograph: BORIC ACID
GLYCERINEActive
Strength: 1 %
Monograph: GLYCERINE
HAMAMELIS VIRGINIANAActive
Strength: 12.5 %
Monograph: HAMAMELIS VIRGINIANA
SODIUM BORATEActive
Strength: 0.215 %
Monograph: SODIUM BORATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.